# A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES)

> **NCT02698839** · NA · UNKNOWN · sponsor: **Sino Medical Sciences Technology Inc.** · enrollment: 539 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** BuMA Supreme
- **DEVICE:** BuMA™

## Key facts

- **NCT ID:** NCT02698839
- **Lead sponsor:** Sino Medical Sciences Technology Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-12
- **Primary completion:** 2018-03
- **Final completion:** 2025-12
- **Target enrollment:** 539 (ESTIMATED)
- **Last updated:** 2024-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02698839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02698839, "A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES)". Retrieved via MORVS 2026-09-29 from https://api.morvs.ai/clinical/NCT02698839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*